Clinical Trial Results: Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating vandetanib and everolimus in patients with advanced or metastatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• Everolimus (everolimus)
• Vandetanib (vandetanib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2026-08-28